EDWARDS LIFESCIENCES CORP (EWL.DE) Stock Fundamental Analysis
Europe - FRA:EWL - US28176E1082 - Common Stock
73.07 EUR
-0.84 (-1.14%)
Taking everything into account, EWL scores 7 out of 10 in our fundamental rating. EWL was compared to 60 industry peers in the Health Care Equipment & Supplies industry. EWL scores excellent points on both the profitability and health parts. This is a solid base for a good stock. While showing a medium growth rate, EWL is valued expensive at the moment. With these ratings, EWL could be worth investigating further for quality investing!.
1. Profitability
1.1 Basic Checks
In the past year EWL was profitable.
In the past year EWL had a positive cash flow from operations.
EWL had positive earnings in each of the past 5 years.
EWL had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
With an excellent Return On Assets value of 10.31%, EWL belongs to the best of the industry, outperforming 88.33% of the companies in the same industry.
EWL has a better Return On Equity (13.40%) than 76.67% of its industry peers.
Looking at the Return On Invested Capital, with a value of 9.83%, EWL is in the better half of the industry, outperforming 80.00% of the companies in the same industry.
EWL had an Average Return On Invested Capital over the past 3 years of 12.44%. This is above the industry average of 8.99%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 10.31% | ||
| ROE | 13.4% | ||
| ROIC | 9.83% |
ROA(3y)21.77%
ROA(5y)18.87%
ROE(3y)29.68%
ROE(5y)26.56%
ROIC(3y)12.44%
ROIC(5y)13.58%
1.3 Margins
EWL has a better Profit Margin (23.25%) than 91.67% of its industry peers.
In the last couple of years the Profit Margin of EWL has grown nicely.
The Operating Margin of EWL (27.73%) is better than 98.33% of its industry peers.
In the last couple of years the Operating Margin of EWL has remained more or less at the same level.
The Gross Margin of EWL (78.19%) is better than 90.00% of its industry peers.
In the last couple of years the Gross Margin of EWL has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 27.73% | ||
| PM (TTM) | 23.25% | ||
| GM | 78.19% |
OM growth 3Y-5.94%
OM growth 5Y-1.04%
PM growth 3Y38.76%
PM growth 5Y26.09%
GM growth 3Y1.43%
GM growth 5Y1.33%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), EWL is creating some value.
EWL has less shares outstanding than it did 1 year ago.
EWL has less shares outstanding than it did 5 years ago.
EWL has a better debt/assets ratio than last year.
2.2 Solvency
EWL has an Altman-Z score of 12.63. This indicates that EWL is financially healthy and has little risk of bankruptcy at the moment.
EWL's Altman-Z score of 12.63 is amongst the best of the industry. EWL outperforms 96.67% of its industry peers.
EWL has a debt to FCF ratio of 0.75. This is a very positive value and a sign of high solvency as it would only need 0.75 years to pay back of all of its debts.
EWL has a better Debt to FCF ratio (0.75) than 93.33% of its industry peers.
A Debt/Equity ratio of 0.06 indicates that EWL is not too dependend on debt financing.
With an excellent Debt to Equity ratio value of 0.06, EWL belongs to the best of the industry, outperforming 86.67% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.06 | ||
| Debt/FCF | 0.75 | ||
| Altman-Z | 12.63 |
ROIC/WACC1.13
WACC8.68%
2.3 Liquidity
EWL has a Current Ratio of 4.00. This indicates that EWL is financially healthy and has no problem in meeting its short term obligations.
With an excellent Current ratio value of 4.00, EWL belongs to the best of the industry, outperforming 90.00% of the companies in the same industry.
EWL has a Quick Ratio of 3.29. This indicates that EWL is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of EWL (3.29) is better than 90.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 4 | ||
| Quick Ratio | 3.29 |
3. Growth
3.1 Past
The earnings per share for EWL have decreased by -3.75% in the last year.
EWL shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 7.13% yearly.
EWL shows a small growth in Revenue. In the last year, the Revenue has grown by 4.67%.
EWL shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 4.58% yearly.
EPS 1Y (TTM)-3.75%
EPS 3Y5.52%
EPS 5Y7.13%
EPS Q2Q%0%
Revenue 1Y (TTM)4.67%
Revenue growth 3Y1.3%
Revenue growth 5Y4.58%
Sales Q2Q%14.67%
3.2 Future
EWL is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 9.50% yearly.
The Revenue is expected to grow by 8.55% on average over the next years. This is quite good.
EPS Next Y0.42%
EPS Next 2Y5.67%
EPS Next 3Y7.57%
EPS Next 5Y9.5%
Revenue Next Year4.33%
Revenue Next 2Y7.03%
Revenue Next 3Y7.98%
Revenue Next 5Y8.55%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
EWL is valuated quite expensively with a Price/Earnings ratio of 32.91.
EWL's Price/Earnings is on the same level as the industry average.
The average S&P500 Price/Earnings ratio is at 25.51. EWL is valued slightly more expensive when compared to this.
A Price/Forward Earnings ratio of 28.96 indicates a quite expensive valuation of EWL.
EWL's Price/Forward Earnings ratio is in line with the industry average.
The average S&P500 Price/Forward Earnings ratio is at 34.98. EWL is around the same levels.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 32.91 | ||
| Fwd PE | 28.96 |
4.2 Price Multiples
EWL's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. EWL is more expensive than 60.00% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of EWL is on the same level as its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 62.2 | ||
| EV/EBITDA | 25.73 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates EWL does not grow enough to justify the current Price/Earnings ratio.
The excellent profitability rating of EWL may justify a higher PE ratio.
PEG (NY)77.66
PEG (5Y)4.62
EPS Next 2Y5.67%
EPS Next 3Y7.57%
5. Dividend
5.1 Amount
No dividends for EWL!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
FRA:EWL (11/18/2025, 7:00:00 PM)
73.07
-0.84 (-1.14%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners88.08%
Inst Owner ChangeN/A
Ins Owners0.16%
Ins Owner ChangeN/A
Market Cap42.90B
Revenue(TTM)5.88B
Net Income(TTM)1.37B
Analysts77.67
Price Target77.32 (5.82%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)7.01%
Min EPS beat(2)4.4%
Max EPS beat(2)9.63%
EPS beat(4)4
Avg EPS beat(4)5.38%
Min EPS beat(4)3.4%
Max EPS beat(4)9.63%
EPS beat(8)5
Avg EPS beat(8)2.27%
EPS beat(12)6
Avg EPS beat(12)1.21%
EPS beat(16)7
Avg EPS beat(16)-0.18%
Revenue beat(2)1
Avg Revenue beat(2)0.37%
Min Revenue beat(2)-0.12%
Max Revenue beat(2)0.85%
Revenue beat(4)1
Avg Revenue beat(4)-0.56%
Min Revenue beat(4)-2.1%
Max Revenue beat(4)0.85%
Revenue beat(8)1
Avg Revenue beat(8)-2.7%
Revenue beat(12)2
Avg Revenue beat(12)-2.12%
Revenue beat(16)2
Avg Revenue beat(16)-2.48%
PT rev (1m)0.89%
PT rev (3m)1.22%
EPS NQ rev (1m)1.1%
EPS NQ rev (3m)1.59%
EPS NY rev (1m)2.21%
EPS NY rev (3m)2.92%
Revenue NQ rev (1m)-0.13%
Revenue NQ rev (3m)-0.06%
Revenue NY rev (1m)0.65%
Revenue NY rev (3m)0.88%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 32.91 | ||
| Fwd PE | 28.96 | ||
| P/S | 8.45 | ||
| P/FCF | 62.2 | ||
| P/OCF | 48.91 | ||
| P/B | 4.87 | ||
| P/tB | 6.81 | ||
| EV/EBITDA | 25.73 |
EPS(TTM)2.22
EY3.04%
EPS(NY)2.52
Fwd EY3.45%
FCF(TTM)1.17
FCFY1.61%
OCF(TTM)1.49
OCFY2.04%
SpS8.64
BVpS14.99
TBVpS10.73
PEG (NY)77.66
PEG (5Y)4.62
Graham Number27.37
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 10.31% | ||
| ROE | 13.4% | ||
| ROCE | 13.97% | ||
| ROIC | 9.83% | ||
| ROICexc | 14.65% | ||
| ROICexgc | 23.24% | ||
| OM | 27.73% | ||
| PM (TTM) | 23.25% | ||
| GM | 78.19% | ||
| FCFM | 13.59% |
ROA(3y)21.77%
ROA(5y)18.87%
ROE(3y)29.68%
ROE(5y)26.56%
ROIC(3y)12.44%
ROIC(5y)13.58%
ROICexc(3y)16.13%
ROICexc(5y)17.4%
ROICexgc(3y)22.87%
ROICexgc(5y)24.4%
ROCE(3y)17.66%
ROCE(5y)19.29%
ROICexgc growth 3Y-5.47%
ROICexgc growth 5Y-8.01%
ROICexc growth 3Y-11.82%
ROICexc growth 5Y-8.6%
OM growth 3Y-5.94%
OM growth 5Y-1.04%
PM growth 3Y38.76%
PM growth 5Y26.09%
GM growth 3Y1.43%
GM growth 5Y1.33%
F-Score6
Asset Turnover0.44
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.06 | ||
| Debt/FCF | 0.75 | ||
| Debt/EBITDA | 0.33 | ||
| Cap/Depr | 138.79% | ||
| Cap/Sales | 3.69% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 56.86% | ||
| Profit Quality | 58.45% | ||
| Current Ratio | 4 | ||
| Quick Ratio | 3.29 | ||
| Altman-Z | 12.63 |
F-Score6
WACC8.68%
ROIC/WACC1.13
Cap/Depr(3y)185.14%
Cap/Depr(5y)236.01%
Cap/Sales(3y)5.48%
Cap/Sales(5y)6.41%
Profit Quality(3y)37.92%
Profit Quality(5y)57.13%
High Growth Momentum
Growth
EPS 1Y (TTM)-3.75%
EPS 3Y5.52%
EPS 5Y7.13%
EPS Q2Q%0%
EPS Next Y0.42%
EPS Next 2Y5.67%
EPS Next 3Y7.57%
EPS Next 5Y9.5%
Revenue 1Y (TTM)4.67%
Revenue growth 3Y1.3%
Revenue growth 5Y4.58%
Sales Q2Q%14.67%
Revenue Next Year4.33%
Revenue Next 2Y7.03%
Revenue Next 3Y7.98%
Revenue Next 5Y8.55%
EBIT growth 1Y4.68%
EBIT growth 3Y-4.72%
EBIT growth 5Y3.49%
EBIT Next Year10.47%
EBIT Next 3Y11.73%
EBIT Next 5Y12.76%
FCF growth 1Y1.45%
FCF growth 3Y-42.99%
FCF growth 5Y-22.01%
OCF growth 1Y-2.42%
OCF growth 3Y-32.1%
OCF growth 5Y-14.39%
EDWARDS LIFESCIENCES CORP / EWL.DE FAQ
Can you provide the ChartMill fundamental rating for EDWARDS LIFESCIENCES CORP?
ChartMill assigns a fundamental rating of 7 / 10 to EWL.DE.
Can you provide the valuation status for EDWARDS LIFESCIENCES CORP?
ChartMill assigns a valuation rating of 2 / 10 to EDWARDS LIFESCIENCES CORP (EWL.DE). This can be considered as Overvalued.
What is the profitability of EWL stock?
EDWARDS LIFESCIENCES CORP (EWL.DE) has a profitability rating of 8 / 10.
What is the valuation of EDWARDS LIFESCIENCES CORP based on its PE and PB ratios?
The Price/Earnings (PE) ratio for EDWARDS LIFESCIENCES CORP (EWL.DE) is 32.91 and the Price/Book (PB) ratio is 4.87.
How financially healthy is EDWARDS LIFESCIENCES CORP?
The financial health rating of EDWARDS LIFESCIENCES CORP (EWL.DE) is 10 / 10.